PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-06-15

Date Title Company
15-Jun-2023 Six-Year Overall Survival Results Added to U.S. Prescribing Information for ADCETRIS® (brentuximab vedotin) as First-Line Treatment for Advanced Hodgkin Lymphoma Businesswire